Circio and GenAssist Collaborate on Gene Therapy for Muscle Disease and In Vivo Cell Therapy

An official at Circio says that by integrating Circio's and GenAssist's complementary technologies, the parties aim to focus on the development of a joint next generation of AAV gene therapy candidates. The post Circio and GenAssist Collaborate on Gene Therapy for Muscle Disease and <i>In Vivo</i> Cell Therapy appeared first on GEN - Genetic Engineering and Biotechnology News.